Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

Xenobiotics reviewer, Study notes of Medical Biochemistry

Xenobiotics reviewer based on Harpers Biochemistry

Typology: Study notes

2019/2020

Uploaded on 08/19/2020

med-drive-ay-2019-20
med-drive-ay-2019-20 🇵🇭

5

(3)

7 documents

1 / 4

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
BIOCHEMISTRY II: XENOBIOTIC METABOLISM
HARPER’S BIOCHEMISTRY TRANS (31ST ED)
JJCL| PAGE 1 OF 4
OUTLINE
I. INTRODUCTION
A. DEFINITIONS
B. CLINICAL IMPORTANCE
B.1. MAIN XENOBIOTICS OF MEDICAL IMPORTANCE
II. PHASES
A. PHASE 1
A.1. CYTOCHROME P450
A.1.1. NOMENCLATURE
A.1.2. ISOFORMS OF CYTOCHROME P450
A.1.3. OVERLAPPING SPECIFICITY
B. PHASE 2
B.1. GLUCURONIDATION
B.2. SULFATION
B.3. GLUTATHIONE CONJUGATION
B.3.1. GLUTATHIONE S-TRANSFERASES
B.3.2. TRANSPORT OF GLUTATHIONE CONJUGATES
B.3.3. GLUTATHIONE ROLES IN METABOLISM
B.4. OTHER REACTIONS
B.4.1. ACETYLATION
B.4.2. METHYLATION
III. RESPONSES TO XENOBIOTICS
A. TOXIC EFFECTS
B. IMMUNOLOGIC EFFECTS
C. CARCINOGENIC EFFECTS
IV. REFERENCES
V. APPENDIX
I. INTRODUCTION
A. DEFINITIONS
Xenobiotics
Xenos [G.
xenos
, foreign]
Wide variety of compounds that are foreign to the body
Naturally occurring compounds in plant foods
Synthetic compounds in medicines
Food additives
Environmental pollutants
Xenobiotic metabolism
Liver where most compounds are metabolized
process of detoxification
o However, it includes metabolites of compounds
that are generally inert, harmless, or biologically
inactive
Importance?
o Inactive prodrug may be activated to an active
compound
o Carcinogenic/mutagenic compounds may be
produced from an initially inactive precursor
FIGURE 1. XENOBIOTIC METABOLISM
B. CLINICAL IMPORTANCE
1. Pharmacology
2. Therapeutics
3. Toxicology
4. Development of transgenic microorganisms and plants
(contain antioxidants etc) containing genes that encode
enzymes
can be used to render potentially hazardous
pollutants harmless
5. Transgenic organisms may be used for biosynthesis of drugs
and other chemicals
B.1. MAIN XENOBIOTICS OF MEDICAL IMPORTANCE
Drugs
Chemical carcinogens
Naturally occurring compounds that have found their way
into our environment
o polychlorinated biphenyls (PCBs)
o insecticides
o pesticides
FIGURE 2. PHASES IN XENOBIOTIC METABOLISM
II. PHASES
Occurs in two phases:
1. Hydroxylation
o Major reaction
o Catalyzed by enzymes that are monooxygenases
or cytochromes P450
2. Conjugation
o Enzymes can catalyze wide range of other
reactions:
Deamination
Dehalogenation
Desulfuration
Epoxidation
Peroxygenation
Reduction
Other enzymes (and their reactions)
Esterases hydrolysis
A. PHASE 1
renders compounds more reactive
Introduces groups that can be conjugated with glucuronic
acid, sulfate, acetate, glutathione, or amino acids in phase 2
metabolism
Produces polar compounds which can be excreted in urine
(water-soluble)
Some cases occur wherein biologically inactive compounds
biologically active
o In these instances, the original xenobiotics are
referred to as prodrugs or procarcinogens
Sometimes additional phase 1 reactions occur
o Example: further hydroxylation converts active
compounds into less active or inactive forms
prior
to conjugation
however, in some cases, the conjugation
is what converts the active products of
phase 1 reactions to inactive compounds
A.1. CYTOCHROME P450
Hydroxylate a wide variety of xenobiotics in phase 1
metabolism
There are at least 57 cytochrome p450 genes in the human
genome (SEE APPENDIX TABLE 2)
It is a heme enzyme
450” = absorption peak at 450 nm
pf3
pf4

Partial preview of the text

Download Xenobiotics reviewer and more Study notes Medical Biochemistry in PDF only on Docsity!

HARPER’S BIOCHEMISTRY TRANS (31ST^ ED) OUTLINE I. INTRODUCTION A. DEFINITIONS B. CLINICAL IMPORTANCE B.1. MAIN XENOBIOTICS OF MEDICAL IMPORTANCE II. PHASES A. PHASE 1 A.1. CYTOCHROME P A.1.1. NOMENCLATURE A.1.2. ISOFORMS OF CYTOCHROME P A.1.3. OVERLAPPING SPECIFICITY B. PHASE 2 B.1. GLUCURONIDATION B.2. SULFATION B.3. GLUTATHIONE CONJUGATION B.3.1. GLUTATHIONE S-TRANSFERASES B.3.2. TRANSPORT OF GLUTATHIONE CONJUGATES B.3.3. GLUTATHIONE ROLES IN METABOLISM B.4. OTHER REACTIONS B.4.1. ACETYLATION B.4.2. METHYLATION III. RESPONSES TO XENOBIOTICS A. TOXIC EFFECTS B. IMMUNOLOGIC EFFECTS C. CARCINOGENIC EFFECTS IV. REFERENCES V. APPENDIX I. INTRODUCTION A. DEFINITIONS Xenobiotics

  • Xenos [G. xenos, foreign]
  • Wide variety of compounds that are foreign to the body
  • Naturally occurring compounds in plant foods
  • Synthetic compounds in medicines
  • Food additives
  • Environmental pollutants Xenobiotic metabolism
  • Liver – where most compounds are metabolized
  • process of detoxification o However, it includes metabolites of compounds that are generally inert, harmless, or biologically inactive
  • Importance? o Inactive prodrug may be activated to an active compound o Carcinogenic/mutagenic compounds may be produced from an initially inactive precursor FIGURE 1. XENOBIOTIC METABOLISM B. CLINICAL IMPORTANCE
  1. Pharmacology
  2. Therapeutics
  3. Toxicology
  4. Development of transgenic microorganisms and plants (contain antioxidants etc) containing genes that encode enzymes
  • can be used to render potentially hazardous pollutants harmless
  1. Transgenic organisms may be used for biosynthesis of drugs and other chemicals B.1. MAIN XENOBIOTICS OF MEDICAL IMPORTANCE
  • Drugs
  • Chemical carcinogens
  • Naturally occurring compounds that have found their way into our environment o polychlorinated biphenyls (PCBs) o insecticides o pesticides FIGURE 2. PHASES IN XENOBIOTIC METABOLISM II. PHASES Occurs in two phases:
  1. Hydroxylation o Major reaction o Catalyzed by enzymes that are monooxygenases or cytochromes P
  2. Conjugation o Enzymes can catalyze wide range of other reactions: ▪ Deamination ▪ Dehalogenation ▪ Desulfuration ▪ Epoxidation ▪ Peroxygenation ▪ Reduction ▪ Other enzymes (and their reactions)
  • Esterases – hydrolysis A. PHASE 1
  • renders compounds more reactive
  • Introduces groups that can be conjugated with glucuronic acid, sulfate, acetate, glutathione, or amino acids in phase 2 metabolism
  • Produces polar compounds which can be excreted in urine (water-soluble)
  • Some cases occur wherein biologically inactive compounds → biologically active o In these instances, the original xenobiotics are referred to as prodrugs or procarcinogens
  • Sometimes additional phase 1 reactions occur o Example: further hydroxylation converts active compounds into less active or inactive forms prior to conjugation ▪ however, in some cases, the conjugation is what converts the active products of phase 1 reactions to inactive compounds A.1. CYTOCHROME P
  • Hydroxylate a wide variety of xenobiotics in phase 1 metabolism
  • There are at least 57 cytochrome p450 genes in the human genome (SEE APPENDIX TABLE 2)
  • It is a heme enzyme
  • “ 450 ” = absorption peak at 450 nm

HARPER’S BIOCHEMISTRY TRANS (31ST^ ED)

  • ~50% of metabolized common drugs that are ingested are metabolized by isoforms of cytP NOTE: CYTOCHROME B5 – HEMOPROTEIN FOUND IN THE MEMBRANES OF SER, MAY BE INVOLVED AS AN E-^ DONOR IN SOME CASES Example reaction: RH + O-O + NADPH + H+^ → R-OH + H 2 O + NADP
  • What’s happening in the reaction above? o Catalysis of transfer of electrons from NADPH to cytP450 (meaning: CYP450 is reduced) o Reduced cytochrome P450 catalyzes reductive activation of molecular oxygen ▪ one atom becomes the hydroxyl group in the substrate, the other is reduced to water, note the color changes (See FIGURE 3 ) FIGURE 3. OVERVIEW OF THE MEMBRANE-ASSOCIATED CYTOCHROME P SYSTEM. HYDROGEN IS ABSTRACTED FROM NADPH AND USED TO REDUCE ONE ATOM OF MOLECULAR OXYGEN TO WATER; THE SECOND OXYGEN ATOM REACTTS WITH THE SUBSTRATE, FORMING A HYDROXYL GROUP A.1.1. NOMENCLATURE
  • Systematic nomenclature based on their amino acid sequence homology
  • For “CYP450” o Root: CYP – cytochrome P
  • Number designating the family (SEE APPENDIX TABLE 1) o Same family if they exhibit 40% or more amino acid sequence identity
  • Capital letter indicating subfamily o Same subfamily if they exhibit more than 55% sequence identity
  • Individual p450s are then assigned numbers in their subfamily
  • Example: o CYP 1 A 1 CYP – root; cytP Family: 1 Subfamily: A First individual member of the subfamily: 1 A.1.2. ISOFORMS
  • Form a superfamily of heme-containing enzymes Major cytochromes P450 involved in drug metabolism: CYP1 (with 3 subfamilies) CYP2 (13 subfamilies) CYP3 (1 subfamily) NOTE: VARIOUS CYTOCHROMES P450 HAVE OVERLAPPING SUBSTRATE SPECIFICITIES. THIS WHY A VERY BROAD RANGE OF XENOBIOTICS CAN BE METABOLIZED Form and Location
  • Liver cells and enterocytes o Where CYP450 are present in greatest amount o Present mainly in membranes of the SER in liver and most tissues which constitute part of the microsomal fraction when tissue is subjected to subcellular fractionation o Hepatic microsomes ▪ CYP450 can comprise as much as 20% of the total protein
  • Adrenal gland o involved in cholesterol and steroid hormone biosynthesis, found in mitochondria as well as in the ER A.1.3. OVERLAPPING SPECIFICITY
  • Explains interactions between drugs and between drugs and nutrients
  1. Most isoforms of CYP450 are inducible Example: Administration of phenobarbital or other drugs o causes hypertrophy of SER and 3-4x increase in the amount of CYP450 in a few days o most cases: ↑ transcription to mRNA o some cases induction stabilization of mRNA or the enzyme protein itself, or ↑ translation of existing mRNA)
  2. Induction underlies drug interactions when effects of one drug are altered by administration of another Examples:
  3. CYP2C9 catabolizes metabolism of anticoagulant warfarin o induced by phenobarbital → increases warfarin metabolism → decreases its effectivity → dose needs to be increased
  4. CYP2E1 catabolizes metabolism of some widely used solvents and compounds found in tobacco smoke o many of which are procarcinogens → induced by ethanol → increases risk of carcinogenicity
  5. Naturally-occurring compounds in foods affect CYP
  • Grapefruit contains furanocoumarins o inhibit cytochrome P450 → affect metabolism of many drugs → may increase or decrease its activity o drugs affected: statins, omeprazole, antihistamines, benzodiazepine, antidepressants
  1. Polymorphism of CYP
  • explains the variation in drug responses by different patients
  • Variants with low catalytic activity – slower metabolism of the substrate, prolonged drug action
  • CYP2A6 – involved in metabolism of nicotine to conitine
  • CYP2A6 alleles: wild type + 2 inactive alleles Individuals with null alleles → impaired metabolism of nicotine, protected against becoming tobacco- dependent smokers → smoke less due to long activity of nicotine, blood and brain conc of nicotine remain elevated for a longer amount of time B. PHASE 2
  • Derivatives from phase 1 are conjugated with molecules (e.g. glucuronic acid, sulfate, or glutathione)
  • Renders derivatives more soluble in water, and are eventually excreted in the urine or bile B.1. GLUCURONIDATION
  • Xenobiotics are glucuronidated in the same way as bile is
  • Uses UDP-glucuronic acid (may attach to oxygen, nitrogen, or sulfur groups of the substrates)
  • Catalyzed by a variety of glucuruonysltransferases (present in both ER and cytosol)
  • Examples of molecules excreted as glucuronides: o 2 - acetylaminofluorene (carcinogen) o Aniline o Benzoic Acid o Meprobamate (Tranquilizer) o Phenol o Many Steroid Hormones B.2. SULFATION
  • Some alcohols, arylamines, phenols
  • Sulfate donor is active sulfate – adenosine 3’-phosphate-5’- phosphosulfate (PAPS)
  • Sulfate donor is the same sulfate donor in other biologic and sulfation reactions B.3. GLUTATHIONE CONJUGATION
  • Tripeptide γ-glutamylcysteinylglycine o for conjugation of electrophilic compounds o forms glutathione S-conjugates that are excreted in urine and bile
  • Reaction catalyzed by S-transferases: R + GSH → R-S-G; R=electrophile Classes of glutathione S-transferases
  1. 4 classes of cytosolic glutathione S-transferase
  2. 2 classes of microsomal membrane-bound enzymes
  3. Distinct kappa class found in mitochondria and peroxisomes

HARPER’S BIOCHEMISTRY TRANS (31ST^ ED) B.4.2. METHYLATION

  • Enzyme: methyltransferases
  • Employs S-adenosylmethionine as the methyl donor FIGURE 9. S-ADENOSYLMETHIONINE. TRANSFERS METHYL GROUP. III. RESPONSES TO XENOBIOTICS
  • Toxic, immunological, carcinogenic
  • Few xenobiotics that do not have some toxic effect if the dose is large enough FIGURE 10. SIMPLIFIED SCHEME SHOWING HOW METABOLISM OF A XENOBIOTIC CAN RESULT IN CELL INJURY, IMMUNOLOGICAL DAMAGE, OR CANCER. In this instance, the conversion of the xenobiotic to a reactive metabolite is catalyzed by a cytochrome P450, and the conversion of the reactive metabolite (eg, an epoxide) to a nontoxic metabolite is catalyzed either by a GSH S-transferase or by epoxide hydrolase.
  • Three general toxic effects: A. CYTOTOXIC EFFECTS
  • Covalent binding of xenobiotic metabolites to macromolecules (includes DNA, RNA, protein)
  • Can lead to cell injury (cytotoxicity) – can be severe enough to cause cell death
  • DNA damage – DNA repair mechanism of the cell activated
  • Involves transfer of multiple ADP-ribose units onto DNA- binding proteins
  • Catalyzed by poly(ADP-ribose polymerase)
  • Source of ADP-ribose: NAD (considerable depletion when there is severe DNA damage)
  • Severe depletion of NAD → severely impaired ATP formation → cell death B. IMMUNOLOGIC EFFECTS
  • Reactive metabolite of a xenobiotic may bind to a protein, acting as a hapten, altering its antigenicity
  • On its own, it will not stimulate antibody production
  • It stimulates antibody production when bound to a protein
  • Resultant antibodies react with both modified and unmodified proteins → can potentially initiate autoimmune disease C. CARCINOGENIC EFFECTS
  • Reactions of some activated xenobiotics with DNA are important in chemical carcinogenesis
  • Some chemicals (eg benzo[α]pyrene) require activation by cytochrome P450 in the endoplasmic reticulum to become carcinogenic (called indirect carcinogens)
  • Activities of xenobiotic-metabolizing enzymes present in the ER help determine whether such compounds become carcinogenic or are detoxified o Enzyme: Epoxide hydrolase
  • In the membranes of ER
  • Give protection against some carcinogens because CYP450 act on procarcinogen substrates to produce epoxides
  • Epoxides – highly reactive and mutagenic or carcinogenic Epoxide hydrolase: react with epoxides to yield dihydrodiols (much less reactive) FIGURE 11. THE REACTION OF EPOXIDE HYDROLASE

IV. REFERENCES

Harper’s Biochemistry Images from: https://www.brainkart.com/article/Drug-elimination--Metabolism_23279/ https://hackyourgut.com/2016/11/28/trying-to-seal-a-leaky-gut-activate-the-pregnane-x- receptor-for-relief/ https://herbisarium.wordpress.com/2016/02/15/xenobiotics-and-biotransformation/ V. APPENDIX TABLE 1. THE FAMILIES OF CYP450 IN HUMAN TISSUES TABLE 2. SOME PROPERTIES OF HUMAN CYTOCHROMES P